Additional Reassuring Data for SARS-CoV-2 Vaccination in Immune-Mediated Inflammatory Diseases, but With a Catch

J Rheumatol. 2024 Apr 1;51(4):332-335. doi: 10.3899/jrheum.2024-0006.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Viral
  • COVID-19 Vaccines* / therapeutic use
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Antibodies, Viral